NOTICE OF UPGRADE

Our websites will be unavailable between the hours of AEST 4AM September 17, 2022 and AEST 11PM on date September 18, 2022

InvestoGain Australia
 

SEARCH LISTED COMPANY


Any AUS or NZ company

Browse Australian listed companies

0-9A B C D E F G H I J K L M N O P Q R S T U V W XY Z

Browse current Australian managed funds

0-9A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

SEARCH PRIVATE COMPANY


SEARCH FUNDS

Find any Australian or New Zealand company or fund (dead or alive) by using SEARCH above or go directly to the site:

ONCOSIL MEDICAL LTD (OSL)

Click here for free access to this company's:
ASX, Legal & CGT Status

Former (or subsequent) names

 FROMTO
ONCOSIL MEDICAL LTD03/06/2013
NEURODISCOVERY LIMITED03/06/2013

Shareholder links

Our website ranking of OSL: rating 4
(4 out of 5)
COMPANY WEBSITE:

 

REGISTRY:

Boardroom Pty Ltd
Level 8, 210 George Street, Sydney NSW 2000
Tel : +61 2 9290 9600 or 1300 737 760
Fax : +61 2 9279 0664 or 1300 653 459
RegistryWebsite RegistryEmail

Company details

ISIN: AU000000OSL3
Address: Level 5, 7 Eden Park Drive, Macquarie Park NSW, 2113
Tel:  +61 2 9223 3344Fax: +61 2 9252 3988

Date first listed: 15/08/2005
Company Secretary: Christian Dal Cin
Sector: Pharmaceuticals & Biotechnology Industry Group: XHJ
Activities: Neurology Research and Development

News & Events

Expand this box to read and print

name changed from NeuroDiscovery Limited

03/06/2013

 

Click here for free access to this company's:
ASX, Legal & CGT Status

Your comments

Please read our Terms before viewing comments.

 

Company Updates

Post your comments here

Please read our Terms before posting comments.
OMISSIONS
    You can post a comment here about this company

    Please click in the "I'm not a robot" box and enter the word/figures you see in the image that then appears.

    loading Posting your comments. Please wait...

     


     

    Click here for free access to this company's:
    ASX, Legal & CGT Status

    Directors' on-market share transactions (last 5)

    rss feeds

    Purchases Sales

    DATEDIRECTORNUMBERPRICEAMOUNT
    30/06/2023Otto Buttula-5,307,693$0.012$63,678
    04/11/2022Brian Leedman927,975$0.048$44,951
    24/08/2021Martin Cross95,000$0.051$4,845
    27/10/2020Christopher Roberts3,000,000$0.135$405,000
    23/10/2020Martin Cross177,727$0.140$24,798

    Click here for the last 20 transactions all companies

    Directors & Executives (current)

    NAMETITLEDATE OF APPT
    Doug CubbinNon Exec Chairman07/08/2023
    Nigel LangeManaging Director, CEO21/01/2021
    Nicholas FalzonCFO23/08/2013
    Christian Dal CinCFO01/06/2023
    Gabriel LiberatoreNon Exec Director14/07/2023

    Date of first appointment, title may have changed.

    Directors & Executives (former)

    NAMETITLEDATE OF APPOINTMENTDATE OF RESIGNATION
    Brian LeedmanNon Exec Director15/09/202229/11/2023
    Otto ButtulaNon Exec Director20/07/202131/08/2023
    Karl PechmannCFO31/03/202024/05/2023
    Ricky SharmaNon Exec Director01/11/202102/03/2023
    Martin CrossIndependent Director28/02/201724/10/2022
    Christopher RobertsExecutive Chairman, Independent Director21/01/201619/10/2021
    Roger AstonNon Exec Director, Non Exec Director28/03/201319/10/2021
    Michael BassettNon Exec Director10/12/201819/10/2021
    Daniel KennyDirector, CEO05/01/201501/12/2020
    Tom MilicevicCFO22/10/201527/09/2019
    Martin RogersDirector03/04/201320/10/2016
    Lawrence GozlanIndependent Director27/02/201404/05/2015
    Neil FrazerExecutive Director, CEO02/07/201328/11/2014
    David McAuliffeNon Exec Director14/04/200513/09/2013
    Simon O'LoughlinNon Exec Director14/03/201202/07/2013
    Bret MattesNon Exec Chairman12/12/201128/03/2013
    Neville BassettNon Exec Director06/08/201014/03/2012
    Kyle HaynesDirector07/10/201014/03/2012

    Date of first appointment, title may have changed.